 | Up a level |
Soborun, N.; Müller, M.; Abdurashidova, T.; Tzimas, G.; Schukraft, S.; Lu, H.; Hugli, O.; Vollenweider, P.; Garnier, A.; Monney, P.; Hullin, R. (2022). Already low drug dose antagonism of the renin-angiotensin aldosterone system decreases 1-year mortality and rehospitalization in old heart failure patients. Biomedicine & pharmacotherapy, 154, p. 113615. Elsevier 10.1016/j.biopha.2022.113615
